Prostate Cancer
Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer - Abstract
March 1, 2013
Androgen deprivation therapy in advanced prostate cancer: Is intermittent therapy the new standard of care? - Abstract
March 1, 2013
The importance of local control in high-risk locally advanced prostate cancer - Abstract
March 1, 2013
Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer - Abstract
March 1, 2013
Targeting the apoptosis pathway in prostate cancer - Abstract
February 28, 2013
Bone-targeting radiopharmaceuticals including radium-223 - Abstract
February 27, 2013
Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer - Abstract
February 27, 2013
Metabolic syndrome and insulin resistance in patients with prostate cancer treated with androgen deprivation hormone - Abstract
February 27, 2013
Prostate cancer and osteoporosis - Abstract
February 27, 2013